Chapter One: Executive Summary

Introduction
Scope and Methodology
Size and Growth Of The Market
Issues and Trends Affecting The Global Market
Leading Competitors

Chapter Two: Introduction

Overview of Cancer
• Biology of Cancer
• Treatments and Symptoms

Types of Products and Administration
Demographics, Prevalence, Incidence, Mortality

Chapter Three: Issues and Trends

Overview
Geographical Trends
• United States

Regulatory Authorities
• Clinical Trials
• New Indications

Direct-To-Consumer Advertising
Lifestyle and Social Issues
Barriers To Adjunctive Therapies
Drug Delivery Advancements
Pain Management Measures
Oxycontin Issues
Cancer-Related Fatigue Issues
Individualized Chemotherapy
Chemotherapy and Memory Loss

Chapter Four: Antinauseants and Antiemetics

Overview
Products
• Serotonin Receptor Antagonists
• Phenothiazines
• Metoclopramide and Other Drugs

Drug Delivery Methods For Antinauseants and Antiemetics
Research And Development
Market Overview By Geographic Region
• United States
• Europe
• Japan
• Rest of World

Competitive Analysis

Chapter Five: Pain Management

Overview
• Pain Pathways
• Primary Cancer Pain
• Breakthrough Cancer Pain
• Cancer Pain Delivery Methods

Description of Products
• Primary Cancer Pain Medications
• Breakthrough Cancer Pain Medications

Research and Development
Market Overview By Geographic Region
• United States
• Europe
• Japan
• Rest of World

Competitive Analysis

Chapter Six: Biological Response Modifiers

Overview
Description of Products
• Hematopoietic Growth Factors
• Cytomodulatory Agents

Research And Development
Market Overview By Geographic Region
• United States
• Europe
• Japan
• Rest of World

Competitive Analysis

Chapter Seven: Infection Control

Overview
Description of Products
• Anti-Infectives
• Antifungals

Research And Development
Market Overview By Geographic Region
• United States
• Europe
• Japan
• Rest of World

Competitive Analysis

Chapter Eight: Other Adjunctive Therapies

Overview
Description of Products
• Fatigue
• Anorexia/Cachexia/Weight Loss
• Diarrhea
• Constipation
• Hair Loss

Research And Development
Market Overview By Geographic Region
• United States
• Europe
• Japan
• Rest of World

Competitive Analysis

Chapter Nine: Total Market Size and Forecast

Overview
Total Market Size and Forecast
• Market By Segment
• Market By Region

Competitive Analysis
Market Analysis

Chapter Ten: Company Profiles

Introduction
Competitive Summary
Abbott Laboratories
Amgen, Inc.
Aventis
Bayer Corporation
Chugai Pharmaceutical Company Ltd.
Eli Lilly & Company
Glaxosmithkline Plc
Johnson & Johnson
Kirin Brewery Company Ltd.
Knoll Pharmaceuticals Company (Abbott Laboratories)
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
Roche Group
Roxane Laboratories, Inc.

List of Exhibits

Table 1-1: Cancer Incidence and Deaths as a Percentage to Population by Selected Country/Region 2001
Table 1-2: The Global Market for Adjunctive Therapies in Cancer by Type, 1996-2006
Figure 1-1: The Global Market for Adjunctive Therapies in Cancer Revenues by Type 1996-2006
Figure 1-2: The Global Market for Adjunctive Therapies in Cancer Distribution by Type 1996-2006
Table 2-1: List of Cancers
Table 2-2: Side Effects Associated with Chemotherapy
Table 2-3: Side Effects Associated with Radiation Therapy
Table 2-4: Population by Country 1996-2006
Figure 2-1: Population by Significant Country 1996, 2001, 2006
Table 2-5: Cancer Prevalence by Country 1996-2001
Figure 2-2: Cancer Prevalence by Country 1996-2001
Table 2-6: Cancer Incidence by Country 1996-2001
Figure 2-3: Cancer Incidence by Country 1996-2001
Table 2-7: Cancer Deaths by Country 1996-2001
Figure 2-4: Cancer Deaths by Country
Table 2-8: Cancer Incidence and Deaths as a Percentage to Population by Selected Country/Region 2001
Table 2-9: Cancer Incidence by Type and Country 2001
Table 2-10: Cancer Deaths by Type and Country 200141
Figure 4-1: Incidence of Emesis in Cancer Patients
Table 4-1: Chemotherapy Agents and Level of Emetic Potential
Table 4-2: Selected Prescription Antinauseants, Antiemetics and Others with Antiemetic Properties by Available Delivery Method
Table 4-3: Antinauseants and Antiemetics in Development for Treatment of Cancer related Nausea and Vomiting
Table 4-4: The Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Figure 4-2: The Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Table 4-5: The Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics by Geographic Region 1996-2006
Table 4-6: The Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics Share of Global Market by Geographic Region 1996-2006
Figure 4-3: The Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics, by Geographic Region, 1996-2006
Figure 4-4: The Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics, Share by Geographic Region 2001
Table 4-7: U.S. Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Figure 4-5: U.S. Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Table 4-8: European Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Figure 4-6: European Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Table 4-9: Japanese Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Figure 4-7: Japanese Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Table 4-10: Rest of World Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Figure 4-8: Rest of World Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics 1996-2006
Table 4-11: Leading Suppliers’ Shares of the Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics
Figure 4-9: Leading Suppliers’ Shares of the Global Market for Adjunctive Therapies in Cancer: Antinauseants and Antiemetics
Figure 5-1: Incidence of Pain in Cancer Patients
Table 5-1: The World Health Organization Three-Step Analgesic Ladder
Table 5-2: Selected Prescription Non-Narcotic Analgesics by Available Delivery Method
Table 5-3: Selected Over-the-Counter Non-Narcotic Analgesics by Available Delivery Method
Table 5-4: Selected Prescription Narcotic Analgesics by Available Delivery Method
Table 5-5: Selected Prescription Antidepressants Used for Cancer Pain by Available Delivery Method
Table 5-6: Selected Prescription Anticonvulsants Used for Cancer Pain by Available Delivery Method
Table 5-7: Selected Prescription Corticosteroids Used for Cancer Pain by Available Delivery Method
Table 5-8: Selected Prescription Bisphosphonates and Calcitonins Used for Cancer Pain by Available Delivery Method
Table 5-9: Selected Prescription Radiopharmacuticals Used for Cancer Pain by Available Delivery Method
Table 5-10: Pain Management Products in Development for Treatment of Cancer Related Pain
Table 5-11: The Global Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Figure 5-2: The Global Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Table 5-12: The Global Market for Adjunctive Therapies in Cancer: Pain Management, by Geographic Region 1996-2006
Table 5-13: The Global Market for Adjunctive Therapies in Cancer: Pain Management Products Share of Global Market by Geographic Region 1996-2006
Figure 5-3: The Global Market for Adjunctive Therapies in Cancer: Pain Management by Geographic Region 1996-2006
Figure 5-4: The Global Market for Adjunctive Therapies in Cancer: Pain Management, by Percent and Geographic Region 2001
Table 5-14: The Global Market for Adjunctive Therapies in Cancer: Pain Management by Pain Type 1996-2006
Table 5-15: The Global Market for Adjunctive Therapies in Cancer: Pain Management Market Share by Pain Type 1996-2006
Figure 5-5: The Global Market for Adjunctive Therapies in Cancer: Pain Management, by Pain Type, 1996-2006
Figure 5-6: The Global Market for Adjunctive Therapies in Cancer: Pain Management, by Pain Type 2001
Table 5-16: U.S. Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Figure 5-7: U.S. Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Table 5-17: European Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Figure 5-8: European Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Table 5-18: Japanese Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Figure 5-9: Japanese Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Table 5-19: Rest of World Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Figure 5-10: Rest of World Market for Adjunctive Therapies in Cancer: Pain Management 1996-2006
Table 5-20: Leading Suppliers’ Shares of the Global Market for Adjunctive Therapies in Cancer: Pain Management 2001
Figure 5-11: Leading Suppliers’ Shares of the Global Market for Adjunctive Therapies in Cancer: Pain Management, 2001
Figure 6-1: Frequency of Bone Marrow Suppression in Cancer Patients
Table 6-1: Selected Biological Response Modifiers, and Available Delivery Method
Table 6-2: Biological Response Modifiers in Development for Treatment of Cancer related Infection
Table 6-3: The Global Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Figure 6-2: The Global Market for Adjunctive Therapies in Cancer: Biological Response Modifiers
Table 6-4: The Global Market for Adjunctive Therapies in Cancer: Biological Response Modifiers by Geographic Region 1996-2006
Table 6-5: The Global Market for Adjunctive Therapies in Cancer: Biological Response Modifiers Share by Geographic Region, 1996-2006
Figure 6-3: The Global Market for Adjunctive Therapies in Cancer: Biological Response Modifiers by Geographic Region 1996-2006
Figure 6-4: The Global Market for Adjunctive Therapies in Cancer: Biological Response Modifiers Share by Geographic Region 2001
Table 6-6: The U.S. Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Figure 6-5: The U.S. Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Table 6-7: European Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Figure 6-6: European Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Table 6-8: Japanese Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Figure 6-7: Japanese Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Table 6-9: Rest of World Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Figure 6-8: Rest of World Market for Adjunctive Therapies in Cancer: Biological Response Modifiers 1996-2006
Table 6-10: Leading Suppliers’ Shares of the Global Market for Adjunctive Therapies in Cancer Biological Response Modifiers 2001
Figure 6-9: Leading Suppliers’ Shares of the Global Market for Adjunctive Therapies in Cancer Biological Response Modifiers 2001
Table 7-1: Common Infection Sites and Organisms
Figure 7-1: Frequency of Infection in Cancer Patients
Table 7-2: Selected Prescription Anti-infective Agents and Available Delivery Methods
Table 7-3: Selected Prescription Antifungals and Available Delivery Method
Table 7-4: Anti-Infective Agents and Antifungals in Development for Treatment of Cancer related Infection
Table 7-5: The Global Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Figure 7-2: The Global Market for Adjunctive Therapies in Cancer: Infection Control, 1996-2006
Table 7-6: The Global Market for Adjunctive Therapies in Cancer: Infection Control by Geographic Region 1996-2006
Table 7-7: The Global Market for Adjunctive Therapies in Cancer: Infection Control Share by Geographic Region 1996-2006
Figure 7-3: The Global Market for Adjunctive Therapies in Cancer: Infection Control by Geographic Region 1996-2006
Figure 7-4: The Global Market for Adjunctive Therapies in Cancer: Infection Control Share by Geographic Region 2001
Table 7-8: The Global Market for Adjunctive Therapies in Cancer: Infection Control by Type 1996-2006
Table 7-9: The Global Market for Adjunctive Therapies in Cancer: Infection Control Share by Type 1996-2006
Figure 7-5: The Global Market for Adjunctive Therapies in Cancer: Infection Control by Product Type 1996-2006
Figure 7-6: The Global Market for Adjunctive Therapies in Cancer: Infection Control by Product Type 2001
Table 7-10: U.S. Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Figure 7-7: U.S. Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Table 7-11: European Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Figure 7-8: European Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Table 7-12: Japanese Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Figure 7-9: Japanese Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Table 7-13: Rest of World Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Figure 7-10: Rest of World Market for Adjunctive Therapies in Cancer: Infection Control 1996-2006
Table 7-14: Leading Suppliers’ Share of the Global Market for Adjunctive Therapies in Cancer: Infection Control 2001
Figure 7-11: Leading Suppliers’ Share of the Global Market for Adjunctive Therapies in Cancer: Infection Control 2001
Figure 8-1: Frequency of Fatigue in Cancer Patients
Figure 8-2: Incidence of Anorexia/Cachexia/Weight Loss in Cancer Patients
Figure 8-3: Incidence of Diarrhea in Cancer Patients
Figure 8-4: Incidence of Constipation in Cancer Patients
Table 8-1: Selected Chemotherapy Agents and Level of Hair Loss Potential
Figure 8-5: Frequency of Hair Loss in Cancer Patients
Figure 8-6: Prevalence of Various Conditions in Cancer Patients
Table 8-2: Selected Prescription and Non-prescription Products to Minimize Symptoms of Fatigue in Cancer Patients and Available Delivery Method
Table 8-3: Selected Prescription Products for the Treatment of Anorexia/Cachexia in Cancer Patients and Available Delivery Method
Table 8-4: Selected Prescription and Non-prescription Products for the Treatment of Diarrhea in Cancer Patients and Available Delivery Method
Table 8-5: Selected Prescription and Non-prescription Products for the Treatment of Constipation in Cancer Patients and Available Delivery Method
Table 8-6: Other Adjunctive Therapies in Development for Treatment of Cancer
Table 8-7: The Global Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Figure 8-7: The Global Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Table 8-8: The Global Market for Adjunctive Therapies in Cancer: Other Therapies, by Geographic Region, 1996-2006
Table 8-9: The Global Market for Adjunctive Therapies in Cancer Other Therapies Distribution by Geographic Region 1996-2006
Figure 8-8: The Global Market for Adjunctive Therapies in Cancer: Other Therapies by Geographic Region 1996-2006
Figure 8-9: The Global Market for Adjunctive Therapies in Cancer: Other Therapies Distribution by Geographic Region 2001
Table 8-10: U.S. Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Figure 8-10: U.S. Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Table 8-11: European Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Figure 8-11: European Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Table 8-12: Japanese Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Figure 8-12: Japanese Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Table 8-13: Rest of World Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Figure 8-14: Rest of World Market for Adjunctive Therapies in Cancer: Other Therapies 1996-2006
Table 9-1: The Global Market for Adjunctive Therapies in Cancer by Type, 1996-2006
Table 9-2: The Global Market for Adjunctive Therapies in Cancer Distribution by Type 1996-2006
Figure 9-1: The Global Market for Adjunctive Therapies in Cancer Revenues by Type 1996-2006
Figure 9-2: The Global Market for Adjunctive Therapies in Cancer by Type and Percent Distribution, 1996-2006
Figure 9-3: The Global Market for Adjunctive Therapies in Cancer Distribution by Type 2001
Table 9-3: The Global Market for Adjunctive Therapies in Cancer by Geographical Region, 1996-2006
Table 9-4: The Global Market for Adjunctive Therapies in Cancer Distribution by Geographical Region 1996-2006
Figure 9-4: The Global Market for Adjunctive Therapies in Cancer Revenues by Geographical Region 1996-2006
Figure 9-5: The Global Market for Adjunctive Therapies in Cancer by Geographical Region and Percent Distribution, 1996-2006
Figure 9-6: The Global Market for Adjunctive Therapies in Cancer by Percent and Geographical Region, 2001
Table 9-5: Leading Suppliers, Products, and Segments of Participation 2001